TD ASSET MANAGEMENT INC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 134 filers reported holding CARA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.5%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$300,000
+29.3%
19,4000.0%0.00%
Q2 2021$232,000
-44.9%
19,4000.0%0.00%
Q1 2021$421,000
+43.2%
19,4000.0%0.00%
Q4 2020$294,000
+19.0%
19,4000.0%0.00%
Q3 2020$247,000
-25.6%
19,4000.0%0.00%
Q2 2020$332,000
+29.7%
19,4000.0%0.00%
Q1 2020$256,000
-18.2%
19,4000.0%0.00%
Q4 2019$313,000
-11.8%
19,4000.0%0.00%
-100.0%
Q3 2019$355,000
-14.9%
19,4000.0%0.00%0.0%
Q2 2019$417,000
+9.4%
19,4000.0%0.00%0.0%
Q1 2019$381,000
+51.2%
19,4000.0%0.00%
Q4 2018$252,000
-45.8%
19,4000.0%0.00%
-100.0%
Q3 2018$465,000
+25.0%
19,4000.0%0.00%0.0%
Q2 2018$372,000
+56.3%
19,400
+1.0%
0.00%
Q1 2018$238,000
+1.3%
19,2000.0%0.00%
Q4 2017$235,000
-12.3%
19,200
-2.0%
0.00%
Q3 2017$268,000
+17.5%
19,600
+32.4%
0.00%
Q2 2017$228,00014,8000.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$47,864,00031.00%
Chescapmanager LLC 1,484,303$25,382,0004.27%
Cypress Capital Management LLC (WY) 179,920$3,077,0003.07%
DAFNA Capital Management LLC 371,033$6,345,0001.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$10,715,0000.98%
Prosight Management, LP 86,965$1,487,0000.64%
ETF MANAGERS GROUP, LLC 901,714$15,419,0000.55%
Carmignac Gestion 2,065,153$35,314,0000.49%
Ikarian Capital, LLC 273,524$4,677,0000.37%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$39,330,0000.32%
View complete list of CARA THERAPEUTICS INC shareholders